Reuters logo
BRIEF-EMA recommends approval of Pfizer's lifmior drug
December 16, 2016 / 12:43 PM / 9 months ago

BRIEF-EMA recommends approval of Pfizer's lifmior drug

Dec 16 (Reuters) - European Medicines Agency:

* Recommends approval of Pfizer's lifmior (Etanercept) for the treatment of rheumatoid arthritis Source text for Eikon: (bit.ly/2gItj6L) Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below